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Regarding “Asymptomatic carotid artery stenosis—
Medical therapy alone versus medical therapy plus
carotid endarterectomy or stenting”
Current medical intervention alone is now best for prevention of
stroke associated with asymptomatic carotid stenosis.1 Dr Schneider’s
case against this conclusion is fatally flawed because it is based on an
outdated, over-reliance on borderline significant results from histori-
cal randomized carotid endarterectomy (CEA) trials (“level 1 evi-
dence”) and underestimation of the counter-evidence.2,3
There have been significant falls in average annual rates of ipsilat-
eral and any territory stroke ( transient ischemic attack)withmedical
intervention alone since the early 1980s, with rates falling below those
of patients who received medical intervention and CEA in random-
ized trials.1 These falls were revealed after a thorough, systematic
literature analysis limited to prospective studies of100 patients with
direct-imaging-identified asymptomatic carotid stenosis of 50% or
75% using North American Symptomatic Carotid Endarterectomy
Trial (NASCET)/NASCET comparable measurements. There were
3724 patients, including those from randomized trials, with average
follow-up of about 3 to 4 years. Whether randomized to surgery or
not, patients had similar stenosis severity (50% or 60% in the
randomized trials, for example). Subsequent publications have been
consistent with a continuing drop in stroke event rates with current
medical intervention alone. The conclusion that current medical
intervention alone is now best for prevention of stroke associatedwith
asymptomatic severe carotid stenosis is based on all currently available
evidence; these published annual stroke rates, consideration of non-
stroke/death atherosclerotic complications, observations of routine
practice CEA, and cost.1
We need more measurements of the average annual risk of
stroke, and other major atherosclerotic complications, among
well-described patients with asymptomatic carotid stenosis receiv-
ing well-described current medical intervention alone. Current
commonplace and current best medical intervention are ever-evolving
concepts that will vary across time and locality. Therefore, we need
to make such measurements an ongoing, integral part of routine
practice around the world. We also need to keep defining current
best medical intervention by updating optimal ways to identify and
treat risk factors to best prevent clinical complications.
The average annual ipsilateral stroke rate amonghospital-referred
patients with asymptomatic severe carotid stenosis receiving current
medical intervention alone is now expected to be consistently 1%,
perhaps0.5%.Therefore, what clinical or economic benefit could be
expected for routine practice from further randomized trials of addi-
tional surgery/stenting in this setting? None! Instead, we need to
identify the small minority with sufficiently higher than average risk
despite current best medical intervention alone. We can expect such
patients will also be at higher risk from CEA/stenting. Therefore, we
would need to randomize them to additional CEA/stenting (and
only them!). The results of such randomized trials will not be available
for10 to 15 years. So, in the meantime, we should stop operating,
stop stenting, deliver better current best medical intervention, and
better measures!
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Reply
The letter from Dr Abbott adds nothing new, except perhaps a
bit of bluster. I need to know how to manage real live patients at risk
for stroke from severe asymptomatic carotid stenosis, and I am not
going to find out fromDrAbbott’s letter. The paper referenced in the
letter byDrAbbott as holding the answer to this problemwas cited by
both authors in the preceding debate.1 I encourage everyone to read
this paper cited by both debaters andby the letter fromDrAbbott and
examine the studies from which it is derived. Many of you will be
horrified with what you find; small, poorly controlled studies of
patients with no neurological examination, lots of crossovers, unclear
duplex findings, and many minor carotid lesions. We are being told
that this conclusion has been “discovered” through a review of these
earlier studies. The answer was apparently right there all the time; a
gold nugget in a boggy field.
The Asymptomatic Carotid Surgery Trial was better con-
ducted than any single study cited as a reason to abandon repair of
carotid stenosis.2 When have marginal studies, even a lot of them,
trumped level 1 evidence? When does a review paper hold the
answer while a well-conducted randomized controlled trial does
not? The debate was written prior to the publication of the Carotid
Revascularization Endarterectomy versus Stenting Trial but the
letter by Dr. Abbott was written since, with no moderation in
tone.3 Now we all know that asymptomatic patients had a periop-
erative stroke/death risk of 1.4% with endarterectomy. Suppose
the annual risk of stroke without repair is as low as 1% as has been
suggested (we still don’t know)? Any patient with a life expectancy
of more than a few years could still potentially benefit from repair.
It may come to pass that medical management solves this
problem; no doubt there is a trend. However, evidence being cited
that repair should be abandoned is not conclusive. Only the
convictions of the proponents of that nihilistic approach are clear.
How can anyone be so certain that it is time to abandon repair?
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